Results 211 to 220 of about 384,522 (254)

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults. [PDF]

J Virol
van Pul L, Rosendahl Huber SK, Jacobi R, Hendriks M, van Schuijlenburg R, van Sleen Y, Bijvank E, de Wit J, van Beek J.   +8 more
europepmc   +1 more source

Frequency and Demographic Patterns of SARS-CoV-2 and Influenza Virus Infections in Khuzestan: A Retrospective Observational Study (2021-2023). [PDF]

Adv Virol
Nasimzadeh S, Mohammadpour Fard R, Ghasemi S, Marhemati F, Movahedi M, Rashtizadeh B, Darvishi F, Hesam S, Makvandi M, Khodadadi A, Torabizadeh M, Saki N, Balar N, Rashno M.   +13 more
europepmc   +1 more source

Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Vaughan A, Joyce A, Traub E, Jae M, Beeler E, Paiva E, Ananian K, Holiday C, Jefferson S, Richardson J, Munna C, Chan C, Scott T, Kojima N, Seneviratne T, Mellis A, Olsen SJ, Green N, Feaster M, Terashita D, Balter S, Levine MZ, Middleton J, de St Maurice A.   +23 more
europepmc   +1 more source

Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization. [PDF]

J Infect Dis
Villafuerte D, Fall A, Akin E, Werner AP, Pinsley M, Vue Y, Abdullah O, Zhuang TX, Norton JM, Rothman RE, Fenstermacher KZJ, Morris CP, Klein E, Pekosz A, Mostafa HH.   +14 more
europepmc   +1 more source

Correction to "Burden of Severe Disease Associated With Influenza, SARS-CoV-2 and RSV in Spain During the 2024-2025 Winter Season." [PDF]

Influenza Other Respir Viruses
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Influenza

Der Internist, 2021
Influenza is the infectious disease with the highest population-based mortality. It mainly affects those aged 60 years and older, mainly due to immune senescence, which also favors complicated courses and compromises vaccine effectiveness. Therefore, various approaches have been developed for more immunogenic vaccines, which are now available for use ...
Anja, Kwetkat, Hans Jürgen, Heppner, Anne-Sophie, Endres, Andreas, Leischker   +3 more
openaire   +2 more sources